A gene expression profile study of sporadic pancreatic NETs revealed down regulation of TSC2 and PTEN, two key inhibitors of the AKT/mTOR pathway in most of the sporadic NETs. This evidence concerns the gene AKT1 and pancreatic neuroendocrine tumor.